celecoxib has been researched along with Prostatitis in 6 studies
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of celecoxib in treating inflammatory(Type IIIA) chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS-IIIA type)." | 9.11 | [Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis]. ( Liu, J; Yang, W; Ye, Z; Zeng, X; Zhang, X; Zhou, S; Zhou, X, 2004) |
| "To evaluate the efficacy and safety of celecoxib in treating inflammatory(Type IIIA) chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS-IIIA type)." | 5.11 | [Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis]. ( Liu, J; Yang, W; Ye, Z; Zeng, X; Zhang, X; Zhou, S; Zhou, X, 2004) |
| " Pelvic pain had developed in EAP rats, which was attenuated by a single treatment with celecoxib or pregabalin, suggesting that EAP is an appropriate model for prostatitis-related pain." | 3.88 | Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain. ( Kotera, T; Kurita, M; Oka, M; Okamoto, K; Yamaguchi, H, 2018) |
| " The prostate tissue penetration and related pharmacokinetic parameters were evaluated by non-compartmental analysis." | 1.48 | Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue. ( Radhakrishnan, J; Radhakrishnan, R; Yellepeddi, VK, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aydogdu, O | 1 |
| Perez, F | 1 |
| Aronsson, P | 1 |
| Uyar Gocun, P | 1 |
| Carlsson, T | 1 |
| Sandner, P | 1 |
| Patel, B | 1 |
| Winder, M | 1 |
| Zhang, Y | 1 |
| Li, X | 1 |
| Zhou, K | 1 |
| Zhou, M | 1 |
| Xia, K | 1 |
| Xu, Y | 1 |
| Sun, X | 1 |
| Zhu, Y | 1 |
| Cui, C | 1 |
| Deng, C | 1 |
| Yellepeddi, VK | 1 |
| Radhakrishnan, J | 1 |
| Radhakrishnan, R | 1 |
| Kurita, M | 1 |
| Yamaguchi, H | 1 |
| Okamoto, K | 1 |
| Kotera, T | 1 |
| Oka, M | 1 |
| Funahashi, Y | 1 |
| O'Malley, KJ | 1 |
| Kawamorita, N | 1 |
| Tyagi, P | 1 |
| DeFranco, DB | 1 |
| Takahashi, R | 1 |
| Gotoh, M | 1 |
| Wang, Z | 1 |
| Yoshimura, N | 1 |
| Zeng, X | 1 |
| Ye, Z | 1 |
| Yang, W | 1 |
| Liu, J | 1 |
| Zhang, X | 1 |
| Zhou, X | 1 |
| Zhou, S | 1 |
1 trial available for celecoxib and Prostatitis
| Article | Year |
|---|---|
[Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis].
Topics: Adult; Celecoxib; Chronic Disease; Cyclooxygenase Inhibitors; Humans; Male; Middle Aged; Prostatitis | 2004 |
5 other studies available for celecoxib and Prostatitis
| Article | Year |
|---|---|
Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitis.
Topics: Animals; Benzoates; Biphenyl Compounds; Celecoxib; Chronic Disease; Cystitis; Guanylate Cyclase; Hum | 2022 |
Influence of Experimental Autoimmune Prostatitis on Sexual Function and the Anti-inflammatory Efficacy of Celecoxib in a Rat Model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Celecoxib; Depression; Diseas | 2020 |
Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Celecoxib; | 2018 |
Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
Topics: Analgesics; Animals; Autoimmune Diseases; Celecoxib; Chemokines; Chronic Pain; Cytokines; Disease Mo | 2018 |
Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.
Topics: Androgens; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Mod | 2014 |